Polymyxin B - Global Top Players Market Share and Ranking 2025- YH Research

日本语 | 中文

Home > Reports >Medical Care > Polymyxin B - Global Top Players Market Share and Ranking 2025

Polymyxin B - Global Top Players Market Share and Ranking 2025

Publication Date: 2025-12-05
Report Id: 2859773
Industry: Medical Care
Report Page: 120
Chart: 119

PDF Download

Publication Date: 2025-12-05
Report Id: 2859773
Industry: Medical Care
Report Page: 120
Chart: 119

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 Polymyxin B Definition
1.2 Global Polymyxin B Market Size and Forecast
1.2.1 By Consumption Value, Global Polymyxin B Market Size, 2020-2031
1.2.2 By Sales Quantity, Global Polymyxin B Market Size, 2020-2031
1.2.3 Global Polymyxin B Average Selling Price (ASP), 2020-2031
1.3 China Polymyxin B Market Size and Forecast
1.3.1 By Consumption Value, China Polymyxin B Market Size, 2020-2031
1.3.2 By Sales Quantity, China Polymyxin B Market Size, 2020-2031
1.3.3 China Polymyxin B Average Selling Price (ASP), 2020-2031
1.4 Share of China Polymyxin B Market with Respect to the Global Market
1.4.1 By Consumption Value, China Polymyxin B Market Share in Global, 2020-2031
1.4.2 By Sales Quantity, China Polymyxin B Market Share in Global, 2020-2031
1.4.3 Polymyxin B Market Size: China VS Global, 2020-2031
1.5 Polymyxin B Market Dynamics
1.5.1 Polymyxin B Market Drivers
1.5.2 Polymyxin B Market Restraints
1.5.3 Polymyxin B Industry Trends
1.5.4 Polymyxin B Industry Policy

2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Polymyxin B, Global Market Share by Company, 2020-2025
2.2 By Sales Quantity of Polymyxin B, Global Market Share by Company, 2020-2025
2.3 Polymyxin B Average Selling Price (ASP) by Company, 2020-2025
2.4 Global Polymyxin B Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Polymyxin B Concentration Ratio
2.6 Global Polymyxin B Mergers & Acquisitions, Expansion Plans
2.7 Global Polymyxin B Manufacturers Product Type
2.8 Head Office and Polymyxin B Production Site of Key Manufacturer
2.9 Polymyxin B Capacity of Major Manufacturers and Future Plan

3 China Leading Manufacturers and Market Share
3.1 By Revenue of Polymyxin B, China Market Share by Company, 2020-2025
3.2 By Sales Quantity of Polymyxin B, China Market Share by Company, 2020-2025
3.3 China Polymyxin B Polymyxin B Participants, Market Position (Tier 1, Tier 2, and Tier 3)

4 Global Producing Regions
4.1 Global Polymyxin B Capacity, Output and Capacity Utilization, 2020-2031
4.2 Global Polymyxin B Capacity by Region
4.3 Global Polymyxin B Production & Forecast by Region, 2020 VS 2024 VS 2031
4.4 Global Polymyxin B Production by Region, 2020-2031
4.5 Global Polymyxin B Production Market Share & Forecast by Region, 2020-2031

5 Industry Chain Analysis
5.1 Polymyxin B Industry Chain
5.2 Polymyxin B Upstream Analysis
5.2.1 Polymyxin B Core Raw Materials
5.2.2 Main Manufacturers of Polymyxin B Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Polymyxin B Production Mode
5.6 Polymyxin B Procurement Model
5.7 Polymyxin B Industry Sales Model and Sales Channels
5.7.1 Polymyxin B Sales Model
5.7.2 Polymyxin B Typical Distributors

6 Sights by Type
6.1 Polymyxin B Classification by Type
6.1.1 Injection Polymyxins
6.1.2 Oral Polymyxins
6.1.3 Topical Polymyxins
6.2 by Type, Global Polymyxin B Consumption Value & CAGR, 2020 VS 2024 VS 2031
6.3 by Type, Global Polymyxin B Consumption Value, 2020-2031
6.4 by Type, Global Polymyxin B Sales Quantity, 2020-2031
6.5 by Type, Global Polymyxin B Average Selling Price (ASP), 2020-2031

7 Sights by Source
7.1 Polymyxin B Classification by Source
7.1.1 Natural Fermentation Polymyxin B
7.1.2 Semi-Synthetic Polymyxin B
7.1.3 Purified Fermentation Polymyxin B
7.2 by Source, Global Polymyxin B Consumption Value & CAGR, 2020 VS 2024 VS 2031
7.3 by Source, Global Polymyxin B Consumption Value, 2020-2031
7.4 by Source, Global Polymyxin B Sales Quantity, 2020-2031
7.5 by Source, Global Polymyxin B Average Selling Price (ASP), 2020-2031

8 Sights by Application
8.1 Polymyxin B Segment by Application
8.1.1 Intestinal Disease
8.1.2 Infection
8.1.3 Septicemia
8.1.4 Peritonitis
8.1.5 Others
8.2 by Application, Global Polymyxin B Consumption Value & CAGR, 2020 VS 2024 VS 2031
8.3 by Application, Global Polymyxin B Consumption Value, 2020-2031
8.4 by Application, Global Polymyxin B Sales Quantity, 2020-2031
8.5 by Application, Global Polymyxin B Price, 2020-2031

9 Sales Sights by Region
9.1 By Region, Global Polymyxin B Consumption Value, 2020 VS 2024 VS 2031
9.2 By Region, Global Polymyxin B Consumption Value, 2020-2031
9.3 By Region, Global Polymyxin B Sales Quantity, 2020-2031
9.4 North America
9.4.1 North America Polymyxin B Market Size & Forecasts, 2020-2031
9.4.2 By Country, North America Polymyxin B Market Size Market Share
9.5 Europe
9.5.1 Europe Polymyxin B Market Size & Forecasts, 2020-2031
9.5.2 By Country, Europe Polymyxin B Market Size Market Share
9.6 Asia Pacific
9.6.1 Asia Pacific Polymyxin B Market Size & Forecasts, 2020-2031
9.6.2 By Country/Region, Asia Pacific Polymyxin B Market Size Market Share
9.7 South America
9.7.1 South America Polymyxin B Market Size & Forecasts, 2020-2031
9.7.2 By Country, South America Polymyxin B Market Size Market Share
9.8 Middle East & Africa

10 Sales Sights by Country Level
10.1 By Country, Global Polymyxin B Market Size & CAGR, 2020 VS 2024 VS 2031
10.2 By Country, Global Polymyxin B Consumption Value, 2020-2031
10.3 By Country, Global Polymyxin B Sales Quantity, 2020-2031
10.4 United States
10.4.1 United States Polymyxin B Market Size, 2020-2031
10.4.2 by Type, United States Polymyxin B Sales Quantity Market Share, 2024 VS 2031
10.4.3 by Application, United States Polymyxin B Sales Quantity Market Share, 2024 VS 2031
10.5 Europe
10.5.1 Europe Polymyxin B Market Size, 2020-2031
10.5.2 by Type, Europe Polymyxin B Sales Quantity Market Share, 2024 VS 2031
10.5.3 by Application, Europe Polymyxin B Sales Quantity Market Share, 2024 VS 2031
10.6 China
10.6.1 China Polymyxin B Market Size, 2020-2031
10.6.2 by Type, China Polymyxin B Sales Quantity Market Share, 2024 VS 2031
10.6.3 by Application, China Polymyxin B Sales Quantity Market Share, 2024 VS 2031
10.7 Japan
10.7.1 Japan Polymyxin B Market Size, 2020-2031
10.7.2 by Type, Japan Polymyxin B Sales Quantity Market Share, 2024 VS 2031
10.7.3 by Application, Japan Polymyxin B Sales Quantity Market Share, 2024 VS 2031
10.8 South Korea
10.8.1 South Korea Polymyxin B Market Size, 2020-2031
10.8.2 by Type, South Korea Polymyxin B Sales Quantity Market Share, 2024 VS 2031
10.8.3 by Application, South Korea Polymyxin B Sales Quantity Market Share, 2024 VS 2031
10.9 Southeast Asia
10.9.1 Southeast Asia Polymyxin B Market Size, 2020-2031
10.9.2 by Type, Southeast Asia Polymyxin B Sales Quantity Market Share, 2024 VS 2031
10.9.3 by Application, Southeast Asia Polymyxin B Sales Quantity Market Share, 2024 VS 2031
10.10 India
10.10.1 India Polymyxin B Market Size, 2020-2031
10.10.2 by Type, India Polymyxin B Sales Quantity Market Share, 2024 VS 2031
10.10.3 by Application, India Polymyxin B Sales Quantity Market Share, 2024 VS 2031
10.11 Middle East & Africa
10.11.1 Middle East & Africa Polymyxin B Market Size, 2020-2031
10.11.2 by Type, Middle East & Africa Polymyxin B Sales Quantity Market Share, 2024 VS 2031
10.11.3 by Application, Middle East & Africa Polymyxin B Sales Quantity Market Share, 2024 VS 2031

11 Manufacturers Profile
11.1 Pfizer
11.1.1 Pfizer Company Information, Head Office, Market Area, and Industry Position
11.1.2 Pfizer Polymyxin B Models, Specifications, and Application
11.1.3 Pfizer Polymyxin B Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
11.1.4 Pfizer Company Profile and Main Business
11.1.5 Pfizer Recent Developments
11.2 Zhejiang Hisun Pharmaceutical
11.2.1 Zhejiang Hisun Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
11.2.2 Zhejiang Hisun Pharmaceutical Polymyxin B Models, Specifications, and Application
11.2.3 Zhejiang Hisun Pharmaceutical Polymyxin B Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
11.2.4 Zhejiang Hisun Pharmaceutical Company Profile and Main Business
11.2.5 Zhejiang Hisun Pharmaceutical Recent Developments
11.3 Xellia Pharmaceuticals
11.3.1 Xellia Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
11.3.2 Xellia Pharmaceuticals Polymyxin B Models, Specifications, and Application
11.3.3 Xellia Pharmaceuticals Polymyxin B Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
11.3.4 Xellia Pharmaceuticals Company Profile and Main Business
11.3.5 Xellia Pharmaceuticals Recent Developments
11.4 Cipla
11.4.1 Cipla Company Information, Head Office, Market Area, and Industry Position
11.4.2 Cipla Polymyxin B Models, Specifications, and Application
11.4.3 Cipla Polymyxin B Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
11.4.4 Cipla Company Profile and Main Business
11.4.5 Cipla Recent Developments
11.5 Lupin
11.5.1 Lupin Company Information, Head Office, Market Area, and Industry Position
11.5.2 Lupin Polymyxin B Models, Specifications, and Application
11.5.3 Lupin Polymyxin B Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
11.5.4 Lupin Company Profile and Main Business
11.5.5 Lupin Recent Developments
11.6 B. Braun
11.6.1 B. Braun Company Information, Head Office, Market Area, and Industry Position
11.6.2 B. Braun Polymyxin B Models, Specifications, and Application
11.6.3 B. Braun Polymyxin B Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
11.6.4 B. Braun Company Profile and Main Business
11.6.5 B. Braun Recent Developments
11.7 Shanghai Pharmaceutical
11.7.1 Shanghai Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
11.7.2 Shanghai Pharmaceutical Polymyxin B Models, Specifications, and Application
11.7.3 Shanghai Pharmaceutical Polymyxin B Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
11.7.4 Shanghai Pharmaceutical Company Profile and Main Business
11.7.5 Shanghai Pharmaceutical Recent Developments
11.8 Novartis Sandoz
11.8.1 Novartis Sandoz Company Information, Head Office, Market Area, and Industry Position
11.8.2 Novartis Sandoz Polymyxin B Models, Specifications, and Application
11.8.3 Novartis Sandoz Polymyxin B Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
11.8.4 Novartis Sandoz Company Profile and Main Business
11.8.5 Novartis Sandoz Recent Developments
11.9 Alkem Labs
11.9.1 Alkem Labs Company Information, Head Office, Market Area, and Industry Position
11.9.2 Alkem Labs Polymyxin B Models, Specifications, and Application
11.9.3 Alkem Labs Polymyxin B Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
11.9.4 Alkem Labs Company Profile and Main Business
11.9.5 Alkem Labs Recent Developments
11.10 Par Pharmaceutical
11.10.1 Par Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
11.10.2 Par Pharmaceutical Polymyxin B Models, Specifications, and Application
11.10.3 Par Pharmaceutical Polymyxin B Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
11.10.4 Par Pharmaceutical Company Profile and Main Business
11.10.5 Par Pharmaceutical Recent Developments
11.11 Gland Pharma
11.11.1 Gland Pharma Company Information, Head Office, Market Area, and Industry Position
11.11.2 Gland Pharma Polymyxin B Models, Specifications, and Application
11.11.3 Gland Pharma Polymyxin B Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
11.11.4 Gland Pharma Company Profile and Main Business
11.11.5 Gland Pharma Recent Developments
11.12 Hikma
11.12.1 Hikma Company Information, Head Office, Market Area, and Industry Position
11.12.2 Hikma Polymyxin B Models, Specifications, and Application
11.12.3 Hikma Polymyxin B Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
11.12.4 Hikma Company Profile and Main Business
11.12.5 Hikma Recent Developments
11.13 Merck
11.13.1 Merck Company Information, Head Office, Market Area, and Industry Position
11.13.2 Merck Polymyxin B Models, Specifications, and Application
11.13.3 Merck Polymyxin B Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
11.13.4 Merck Company Profile and Main Business
11.13.5 Merck Recent Developments
11.14 Fresenius Kabi
11.14.1 Fresenius Kabi Company Information, Head Office, Market Area, and Industry Position
11.14.2 Fresenius Kabi Polymyxin B Models, Specifications, and Application
11.14.3 Fresenius Kabi Polymyxin B Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
11.14.4 Fresenius Kabi Company Profile and Main Business
11.14.5 Fresenius Kabi Recent Developments
11.15 Hanmi Pharma
11.15.1 Hanmi Pharma Company Information, Head Office, Market Area, and Industry Position
11.15.2 Hanmi Pharma Polymyxin B Models, Specifications, and Application
11.15.3 Hanmi Pharma Polymyxin B Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
11.15.4 Hanmi Pharma Company Profile and Main Business
11.15.5 Hanmi Pharma Recent Developments

12 Conclusion

13 Appendix
13.1 Research Methodology
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Market Estimation Model
13.4 Disclaimer

According to YH Research, the global market for Polymyxin B should grow from US$ 659 million in 2024 to US$ 889 million by 2031, with a CAGR of 4.3% for the period of 2025-2031.

The strategic recalibration of 2025 U.S. tariff mechanisms is redefining global economic governance norms. This study deciphers the transmission mechanisms of tariff escalation pathways and global policy responses on corporate investment strategies, regional trade networks, and critical material supply architectures.

Polymyxin B

According to YH Research, the global market for Polymyxin B should grow from US$ 659 million in 2024 to US$ 889 million by 2031, with a CAGR of 4.3% for the period of 2025-2031.

Unit: US$ M

www.yhresearch.com

In-depth insight into market trends

In 2024, global Polymyxin B production reached approximately 3.76 thousand tons, with an average global market price of around US$ 165,000 per ton. The gross profit margin of major producers ranges from 35% to 55%. Single-line production capacity typically ranges from 120 to 380 tons per year, depending on fermentation scale, purification capability, and bioreactor efficiency.

Polymyxin B is a peptide-based antibiotic derived from Paenibacillus polymyxa and is known for strong activity against multidrug-resistant Gram-negative bacteria. It is widely used as a last-line therapy for severe infections caused by Pseudomonas aeruginosa, Acinetobacter baumannii, and Klebsiella pneumoniae. Due to its narrow therapeutic window, its API production requires high-purity fermentation, complex extraction, and strict quality control.

The industrial chain includes upstream suppliers of fermentation media, amino acids, peptide precursors, bioreactor components, and pharmaceutical-grade solvents. Midstream manufacturers conduct microbial fermentation, extraction, chromatography purification, lyophilization, and sterile API packaging. Downstream users include injectable-drug manufacturers, hospital pharmacy networks, critical-care units, and anti-infective treatment centers.

By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Polymyxin B market should grow from US$ million in 2024 to US$ million by 2031, with a CAGR of % for the period of 2025-2031. The United States Polymyxin B market should grow from US$ million in 2024 to US$ million by 2031, with a CAGR of % for the period of 2025-2031.

By segment, Intestinal Disease grew percent to account for percent of the total market sales, and Infection grew percent.

This report studies and analyses global Polymyxin B status and future trends, helps the client to determine the Polymyxin B market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Polymyxin B, and provides market size (in Kilotons & US$ million) and Year-over-Year growth, considering 2024 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights
(1) Global Polymyxin B market size, history data 2020-2025, and forecast data 2026-2031, (US$ million) & (Kilotons)
(2) Global Polymyxin B sales, revenue, price by company, market share and industry ranking 2020-2025, (US$ million) & (Kilotons)
(3) China Polymyxin B sales, revenue, price by company, market share and industry ranking 2020-2025, (US$ million) & (Kilotons)
(4) Global Polymyxin B key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Polymyxin B key producing regions, capacity, production, and year over year growth
(6) Polymyxin B industry chains, upstream, midstream and downstream
Market segment by players, this report covers
    Pfizer
    Zhejiang Hisun Pharmaceutical
    Xellia Pharmaceuticals
    Cipla
    Lupin
    B. Braun
    Shanghai Pharmaceutical
    Novartis Sandoz
    Alkem Labs
    Par Pharmaceutical
    Gland Pharma
    Hikma
    Merck
    Fresenius Kabi
    Hanmi Pharma

Market segment by Type, covers
    Injection Polymyxins
    Oral Polymyxins
    Topical Polymyxins

Market segment by Source, covers
    Natural Fermentation Polymyxin B
    Semi-Synthetic Polymyxin B
    Purified Fermentation Polymyxin B

Market segment by Application, can be divided into
    Intestinal Disease
    Infection
    Septicemia
    Peritonitis
    Others

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Polymyxin B product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Polymyxin B market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2025
Chapter 3: China Polymyxin B market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2025
Chapter 4: Global key producing regions of Polymyxin B, percent & CAGR, 2020-2031
Chapter 5: Polymyxin B industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.